• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91].

作者信息

Archimbaud E, Leblond V, Fenaux P, Dombret H, Cordonnier C, Cony-Makoul P, Dreyfus F, Troussard X, Auzanneau G, Stoppa A M

机构信息

Service d'Hématologie, Hôpital Edouard Herriot, Lyon, France.

出版信息

Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S145-8.

PMID:7971264
Abstract
摘要

相似文献

1
[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91].[晚期急性髓系白血病（AML）中序贯化疗联合或不联合粒细胞巨噬细胞集落刺激因子（GM-CSF）：EMA 86和EMA 91方案的现状]
Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S145-8.
2
GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly.GM-IVA，一种针对初发急性髓系白血病的短期诱导疗程，适用于老年人。
Haematologica. 1999 Jun;84(6):562-3.
3
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).粒细胞巨噬细胞集落刺激因子（GM-CSF）用于提高依托泊苷、米托蒽醌和阿糖胞苷（EMA）强化序贯化疗在既往治疗的急性髓系白血病中的疗效：一项多中心随机安慰剂对照试验（EMA91试验）
Leukemia. 1999 Aug;13(8):1214-20. doi: 10.1038/sj.leu.2401474.
4
Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.成人原发性难治性或复发性急性髓系白血病的序贯化疗：II期Gemia方案的结果
Haematologica. 1999 Mar;84(3):226-30.
5
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.乳腺癌辅助化疗期间使用粒细胞集落刺激因子后发生急性髓系白血病或骨髓增生异常综合征。
J Natl Cancer Inst. 2007 Feb 7;99(3):196-205. doi: 10.1093/jnci/djk028.
6
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.皮下重组人白细胞介素-11联合皮下重组人粒细胞巨噬细胞集落刺激因子用于急性髓系白血病（AML）患者诱导期大剂量阿糖胞苷治疗的II期试验：ECOG 3997
Leuk Res. 2006 Jul;30(7):823-7. doi: 10.1016/j.leukres.2005.11.006. Epub 2006 Jan 18.
7
Granulocyte-macrophage colony-stimulating factor in post-remission therapy of acute myeloid leukemia.
Hematol Cell Ther. 1998 Apr;40(2):63-6.
8
Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.伊达比星/阿糖胞苷和米托蒽醌/依托泊苷用于治疗初发性急性髓细胞白血病。
Semin Oncol. 1993 Dec;20(6 Suppl 8):20-6.
9
Granulocyte macrophage--colony stimulating factor (GM-CSF) as adjunct in induction therapy of acute myeloid leukemia.
Indian J Cancer. 1999 Mar;36(1):32-7.
10
Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.接受强化化疗并同时使用G或GM-CSF治疗的急性白血病患者的中性粒细胞恢复时间及不良反应
Rev Invest Clin. 1999 Mar-Apr;51(2):77-80.